Navigation Links
Pharmaceuticals sold in Sweden cause serious environmental harm in India
Date:2/5/2009

Many of the substances in our most common medicines are manufactured in India and China. Some of these factories release large quantities of antibiotics and other pharmaceutical substances to the environment. There is an obvious risk of these releases leading to resistant bacteria.

Research from the Sahlgrenska Academy at University of Gothenburg, Sweden, shows that Sweden is a major consumer of pharmaceutical substances from factories that fail to adequately treat their wastewater. As it is difficult to find out where the pharmaceutical substances are manufactured and how much is released, it is impossible at present for consumers to avoid contributing to this environmental harm.

These findings are presented in the medical journal Regulatory Toxicology and Pharmacology and are highlighted today in a news article in Nature. Last week the research of the Swedish group became headline news in New York Times, Washington Post and Times of India.

"We used to think that pharmaceuticals that ended up in the environment mostly came from the use of the medicines and that the substances were dispersed through wastewater. We now know that certain factories that manufacture substances release very large quantities of active substances," says associate professor Joakim Larsson of the Sahlgrenska Academy in Gothenburg,Sweden, one of the research scientists behind the studies.

The water from the pharmaceutical industries is highly toxic

Joakim Larsson has visited the industrial zone near Hyderabad, India, an important centre for the manufacturing of pharmaceutical substances. Here his research team has taken samples of the water discharged from a treatment plant that treats wastewater from around 90 pharmaceutical factories before it is released.

"We have previously shown that the "treated" water contained exceptionally high levels of various pharmaceutical substances, including several broad-spectrum antibiotics. We estimated that the treatment plant released 45 kilograms of the antibiotic ciprofloxacin in one day, which is equivalent to five times the daily consumption of Sweden," says Larsson.

Such high levels of antibiotics in the water are a cause for alarm as there is an increased risk of spawning resistant bacteria, an issue of global concern. This can lead to those antibiotics that are invaluable today becoming ineffective sooner and not killing the bacteria of tomorrow. In addition, the environment is affected locally by the pollution; In another study by Larsson's team, published this week in Environmental Toxicology and Chemistry, they show that effluent diluted as much as 500 times strongly inhibit the growth of frog tadpoles.

The substances manufactured in Hyderabad are sold in Sweden

Where the active substance in a pharmaceutical product is manufactured is not public information, but the Swedish Medical Products Agency can grant exemptions for research purposes. The researchers analyzed data from the Medical Products Agency for all 242 products on the Swedish market that contained any of nine specific substances*. They found that 123 products contained substances from India and for 74 of the products, 31 per cent, the active substance was manufactured by one of the factories that send their wastewater to the treatment plant outside Hyderabad that was studied.

"The analysis shows quite clearly that a large number of medicinal products on the Swedish market is made by manufacturers that send their effluent to a treatment plant that does not treat their water satisfactorily," says Larsson.

We bear part of the responsibility

" Sweden, which is reputed to have some of the strictest environmental legislation in the world, like other western countries therefore bears a shared responsibility for the environmental problems the medicines we consume cause in India, for example," says Larsson.

But it is impossible for the individual consumer to know today whether a substance in a medicine he or she needs to take may have caused environmental problems in manufacturing.

"It is therefore important that the production chain is made transparent. If consumers are given an opportunity to choose pharmaceutical products they know to be produced in an environmentally friendly way, this could encourage manufacturers to become more environmentally friendly," says Larsson.


'/>"/>

Contact: Joakim Larsson
joakim.larsson@fysiologi.gu.se
46-070-962-1068
University of Gothenburg
Source:Eurekalert

Related medicine news :

1. Lotus Pharmaceuticals, Inc. Purchases Land Use Rights to Grow its Business and Reduce Costs
2. Indevus Pharmaceuticals Announces First Quarter Fiscal 2009 Financial Results
3. Skinvisible Signs Dermatology Agreement With RHEI Pharmaceuticals
4. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the BIO CEO and Investor Conference in New York City
5. Arena Pharmaceuticals to Present at the BIO CEO & Investor Conference
6. ISTA Pharmaceuticals to Present at the 11th Annual BIO CEO & Investor Conference
7. MAP Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Unit Dose Budesonide Collaboration with AstraZeneca
8. Anadys Pharmaceuticals to Present at the BIO CEO & Investor Conference
9. Transdel Pharmaceuticals, Inc. Retains FLP Pharma to Lead Business Development Activities
10. Transcept Pharmaceuticals, Inc. Completes Merger with Novacea, Inc.
11. Major Shareholders Criticize Enzon Pharmaceuticals Management Team in Open Letter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... April 29, 2016 , ... The number of chronically and ... – meaning that there is an urgent need for highly skilled care managers and ... delivering a multi-pronged approach to train and retain care managers, and enhance their skills. ...
(Date:4/28/2016)... ... April 28, 2016 , ... The Dentists ... it has signed a letter of intent with Moda to acquire ... Company (NORDIC). , Started by dentists 36 years ago, TDIC focuses exclusively on ...
(Date:4/28/2016)... ... ... Head Over Heels Athletic Arts’ gymnast, Brooklyn Varize, has qualified to compete in ... University of Montana on April 28-May 1. Varize will compete on Saturday against the ... qualify, Varize needed to place top seven all-around in her respective age group. Varize ...
(Date:4/28/2016)... , ... April 28, 2016 , ... ... the Campaign for Tobacco-Free Kids, a leading force in the fight to reduce ... state and local policies that can help reduce tobacco use. The initiative brings ...
(Date:4/28/2016)... ... April 28, 2016 , ... ... solutions, announces today the availability of its latest software release, NetZoomDC 14.5. ... management and optimization, providing new analytical capabilities that assess complex capacity factors ...
Breaking Medicine News(10 mins):
(Date:4/27/2016)... 27, 2016   Zillion Group today ... technology platform, which specializes in live video consultation. ... digital products, Zillion enables companies to realize the ... to take control of their health. ... – including one-to-one, group and webcast scheduled or ...
(Date:4/27/2016)...  Bayer Animal Health today announced that ... of Florida College of Veterinary Medicine, is the ... Award (BECA). Brittany was selected from entries representing ... of $70,000 in scholarship funds through the 2016 ... provided a total of $232,500 in scholarship awards ...
(Date:4/27/2016)... April 27, 2016 ... the  "Global Anesthesia Disposables Market 2016-2020"  report ... ) ,The global anesthesia disposables market ... of 4.03% during the period 2016-2020.  ... threat to patients, safety. Organizations like the ...
Breaking Medicine Technology: